 |
(6-maleimidocaproyl)hydrazone of doxorubicin |
|---|---|
| Trade Name | |
| Orphan Indication | Soft tissue sarcoma |
| USA Market Approval | USA |
| USA Designation Date | 2011-06-29 00:00:00 |
| Sponsor | NantCell, Inc.;9920 Jefferson Boulevard;Culver City, California, 90232 |
| |
(6-maleimidocaproyl)hydrazone of doxorubicin |
|---|---|
| Trade Name | |
| Orphan Indication | Soft tissue sarcoma |
| USA Market Approval | USA |
| USA Designation Date | 2011-06-29 00:00:00 |
| Sponsor | NantCell, Inc.;9920 Jefferson Boulevard;Culver City, California, 90232 |